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by Alexander Hollaender*
For a number of years I have spent a
great deal of time trying to convince people
of the significance of chemically produced
mutations. There was at first almost no re-
sponse. It was then pointed out to me that
the Drug Research Board of the National
Academy of Sciences-National Research
Council might be interested. The chairman
of this board was Dr. W. S. Middleton, a
pathologist who was formerly Dean at the
University of Wisconsin Medical School,
whom I had met many years ago. Dr. Middle-
ton was responsive, and I presented my ideas
to the Drug Research Board. At that time the
toxicologists and pharmacologists thought
I was a fanatic and paid little attention to
my ideas. Of course we now know that chem-
ically produced mutations may be even more
important than those produced by radia-
tion. With my usual persistence (or stubbor-
ness, if you will) I continued to press for
investigations on chemical mutagenesis, and
gradually the pharmacologists, and the toxi-
cologists too, began to listen. Dr. Middleton
also felt there might be something in what
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I was saying. Subsequently, several round
table discussions were held, the Environ-
mental Mutagen Society was established,
and a number of workshops were coopera-
tively organized by the EMS and the Drug
Research Board.
This brings me back to something that
happened almost twenty years ago. In 1953
the BEAR (Biological Effects of Atomic
Radiation) Committee was appointed by the
National Academy of Sciences. This com-
mittee was under the chairmanship of War-
ren Weaver, then at the Rockefeller Founda-
tion. Dr. Weaver is a mathematician, physi-
cist, and biometrician with an excellent feel-
ing for the basic problems of biology, but
with no training in the field. The BEAR
Committee met many times and in 1955 came
out with their first report, which is still one
of the best I have seen on this subject. War-
ren Weaver did a first-class job of present-
ing scientifically correct material in a non-
technical manner. This and a similar Brit-
ish report led to the formation of
UNSCEAR (The United Nations Scienti-
fic Committee on the Effect of Atomic Ra-
diation) which helped to set the limits on
permissible exposure to radiation.
We are today at about the same stage con-
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with radiation studies 40 years ago. Hope-
fully, some of the methods we have heard
discussed here will lead to the establishment
of similar standards and limitations for
chemical mutagenic compounds.
Before proceeding further, I should re-
emphasize the varying degrees of sophistica-
tion concerning the known methods of test-
ing for chemical mutagens. A great deal of
confusion concerning these tests exists in
the minds of people who are not directly
involved in basic research in mutagens. This
confusion has at least partly been created
by our failure to state clearly which of
these methods can be used under practical
conditions. For instance, what is the back-
ground necessary for an individual to work
with these methods? Can a laboratory tech-
nician handle some of them, or should they
be supervised by a geneticist? I agree it is
not easy to give clearcut statements at the
present time, but if we want our methods
to be used generally these statements have
to be made even if it is necessary to redefine
them later. I think one reason the Food and
Drug Administration has not gone further
in recommending or requiring testing of all
compounds before release for public use is
because we have not provided sufficient rec-
ommendations. There are, of course, other
complicated reasons for this delay. Twenty-
five years ago we were not sure about radia-
tion, but we learned how to describe our
methods in such a way that their limita-
tions could be understood.
Each workshop such as this one, the ones
held at Brown University and Zurich, the
round-table discussions held in Washington,
etc. brings out new ideas, more questions,
and some progress. This is as it should be.
Let us review the testing methods that
have been discussed at this workshop.
The dominant lethal method can be very
useful, but unfortunately some industrial
groups have used it exclusively in testing.
This is a mistake. It is necessary to use a
battery of methods to catch as many muta-
tions as possible. Even today we have not
found a 100%7 reliable method for detect-
ing radiation effects. The dominant-lethal
method for testing for chemical mutagens
seems to be in good enough shape to be
recommended if it is used in conjunction
with other methods.
The translocation method is promising,
but we have not had sufficient experience
under practical conditions. Two chemicals
have been used as described by Dr. Gene-
roso, but this is not adequate. I am reminded
of the tests Cattanach ran in Oak Ridge us-
ing triethylenemelamine and the specific locus
method. He got a highly significant increase
in mutations, especially on certain loci that
were different from the loci most affected
by radiation. We were very enthusiastic and
thought we were really on our way as to
how to use the specific locus method for de-
tecting chemical mutagens, but when other
chemicals were used many of these tests
were negative. Slowly we are learning more
about why they were negative at that time.
We must be wary of overenthusiasm about
any particular method until enough chem-
icals have been tested. I like the transloca-
tion method, but feel we must do further
testing before we recommend it for practical
use. Drs. Generoso and Cumming in Russell's
group in Oak Ridge have demonstrated that
it is a very versatile method of testing, and
they have also helped to point out the im-
portance of chemical mutagenesis.
The host-mediated assay method has been
thoroughly discussed at this meeting, and
I will not go into it further.
I am most impressed with the cytogenetic
methods that have been developed, and I
regret that we did not have more discussion
on the studies by Dr. Miller on micronucleii.
There are much more data available than
were brought out, and I think the micro-
nucleii studies will become an excellent tool
for detecting mutagenic chemicals by chro-
mosome aberrations.
Several good electrophoresis systems are
now available as discussed here. I am espe-
cially acquainted with the methods Neel is
using in attempts to follow the serum pro-
teins in human populations to determine
whether there is an increase in the muta-
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the low mutation rate, as a consequence of
which the resultant numbers tested are
large and the procedure is difficult. It is even
more complicated than the specific locus
method. Anderson, of the MAN Program in
Oak Ridge, is working in close cooperation
with Neel to develop automated methods for
electrophoresis systems. This field is expand-
ing so rapidly that it will be worthwhile hav-
ing it discussed at a future meeting. A chap-
ter in the forthcoming Volume 3 of Chemical
Mutagens: Principles and Methods for Their
Detection will include a chapter by Neel and
Anderson concerning this.
I was pleased that Dr. Shaw discussed
the banding techniques since we are now
beginning to understand the basic structure
of chromosomes so that they can be recog-
nized on the basis of banding. I have been
told that attempts are being made to get
even more detailed structure in regard to
banding and recognizing different parts of
the chromosome. Many more cytogeneticists
who are using chromosome aberrations for
recognizing the mutation effect of chemicals
should get involved in this method.
In the beginning we were criticized for
not involving more pharmacologists in the
mutation studies. It was pointed out that
we were using chemicals, and the job of the
pharmacologists is to study what happens
to chemicals in the body. This was a valid
criticism, and as we have heard in some of
the talks this morning, we have made a
great deal of progress in this direction.
An area that I am surprised we have not
touched, especially in regard to the
dominant-lethal method, is the physiologi-
cal and genetic aspect of reproduction. A
symposium on this subject will be held in
Salvador, Bahia, Brazil this year. For the
first time, geneticists such as Lyon, Oak-
berg, and others will be involved in this
area. We hope to bring about closer con-
tact between the geneticists and the repro-
ductive physiologists. The Latin American
symposium will be quite general in ap-
proach, but the program has been so en-
thusiastically received that another dealing
with the female reproductive physiology is
being planned for 1975 in New Delhi, India.
Again, many geneticists will be included,
and we hope for closer contact between them
and the people working on chemical muta-
tion.
I started out in the mutation field in
microbiology, so I am always enthusiastic
about methods that can be used to acquire
statistical information with a relatively
small amount of work. I am as lazy as the
next fellow, and I like to get as much data
as possible with as little work as necessary,
but I don't think we should fool ourselves
that the data we collect are adequate to
judge for mammalian studies. This work
must be extended into areas where the data
can be applied.
In the final analysis, the mutations will
have to be recognized in human populations.
I mentioned Neel's attempts in this area, and
we should think about other approaches to
this problem. Embryology studies will help,
and there must be better ways of following
changes in populations since we have so
many recognized inherited diseases. Crow
mentioned several hundred that appear in
McKusick's book. I think this is an area which
warrants great effort.
We have heard some discussion about us-
ing the substructure of the cell for recog-
nizing mutations. There are such elegant
methods available for the separation of the
different parts of the cell that there must
be improved ways for following the effect of
chemicals on them. A good part of these
chemical changes affect the cell wall, and
since the nucleii often attach themselves
to or become an integral part of the cell
wall, permeability studies should be en-
couraged. Cell permeability in relation to
genetics will become very important in the
future, especially in regard to chemicals:
whether they get into the cell or not, what
form they are in when they get into the cell,
and how they change in the process of pene-
trating the cell wall, and under what prac-
tical circumstances will the cell wall be
changed.
We will not get very far in the develop-
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tent scientific investigators are trained to
do the work. The Federal government, the
Food and Drug Administration, and the
Cancer Institute give contracts to commer-
cial testing houses to check on mutagenesis
and carcinogenesis, but at this time there
are not sufficient qualified people to prepare
adequate critical evaluations. The tremen-
dous amounts of money being spent through
these contracts could better be used to train
more individuals to do the work competent-
ly. In the long run, this testing should be
done by the commercial houses, but we
should assume the responsibility for mak-
ing certain that they have the proper back-
ground, are critical enough in evaluating
their tests, and that they have qualified gene-
ticists on their staffs. This need makes it
even more surprising that it is so difficult
to get funds for setting up training courses.
We have been trying for the past couple of
years, and so far have not been able to break
the bottleneck of each government agency
thinking someone else should do it. It is
especially shortsighted for the FDA not to
favor the training of individuals who would
be qualified at least to understand the rudi-
mentary aspects of testing and to know the
three most accepted methods. This could be
accomplished in a six to eight-week training
course. The interest of the basic research
laboratories is very intense right now, but
there is not enough support from the com-
mercial houses. I hope that we will have
some discussion on this.
Other aspects of the problem of chemical
mutagenesis are being developed elsewhere.
The Federal Environmental Protection
Agency is interested in the field. The new
Environmental Agency of the United Na-
tions has asked me to outline the organiza-
tion of an international registry of poten-
tially toxic compounds. The intent is not to
eliminate national registries, but rather to
set up additional ones with all feeding into
a central agency, thus allowing more rapid
recognition of toxic chemicals, and faster
dissemination of this information. Again, I
think the success of this program depends
greatly on bringing more well-trained peo-
ple into this area.
Dr. Crow mentioned that it is urgent to
set some numerical value to the danger of
exposure to chemicals. An attempt was made
several years ago to compare radiation ef-
fects and chemical mutagens. During the
war it became mandatory to set a standard
limitation on the amount of radiation to
which humans could safely be exposed. The
value set at that time was much too high, and
has been reduced by the BEAR Committee
and again by the Radiation Protection and
UNSCEAR Committees. It is this sort of
standard we are attempting to set up for
chemical hazards. It will no doubt be a
crude measurement and quite limited in its
application, but it will at least be a "state-
ment" and a starting point that can be
altered and adjusted as more data become
available. I think the time has come for the
National Academy or some similar group to
establish a committee to consider the prob-
lems of chemical mutagenesis. It is to be
hoped that the United Nations will respond
to the survey and organize a registry on an
international basis.
If all this takes place, we will have to call
on you to help because this must be a co-
operative effort. The people in industry, in
the medical profession, in government
laboratories, and investigators in research
laboratories and universities must work to-
gether. Otherwise we won't get anywhere.
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